Roivant Sciences Ltd (NASDAQ:ROIV) price on Wednesday, March 27, rose 7.54% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $10.84.
A look at the stock’s price movement, the close in the last trading session was $10.08. The beta value (5-Year monthly) was 1.37 while the PE ratio in trailing twelve months stood at 2.08. Turning to its 52-week performance, $13.24 and $6.92 were the 52-week high and 52-week low respectively. Overall, ROIV moved -8.14% over the past month.
Roivant Sciences Ltd’s market cap currently stands at around $8.74 billion, with investors looking forward to this quarter’s earnings report slated for Feb 13, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.3, which has seen fiscal year 2024 EPS growth forecast to increase to $4.55 and about -$1.16 for fiscal year 2025. Per the data, EPS growth is expected to be 388.00% for 2024 and -125.50% for the next financial year.
Analysts have a consensus estimate of $33.28 million for the company’s revenue for the quarter, with a low and high estimate of $27.5 million and $40 million respectively. The average forecast suggests up to a 21.60% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue for 2024 to grow to $145.09 million, representing a 136.80% jump on that reported in the last financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that ROIV is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
ROIV’s current price about 1.61% and 1.10% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 54.25, while 7-day volatility ratio is 3.38% and 3.68% in the 30-day chart. Further, Roivant Sciences Ltd (ROIV) has a beta value of 1.35, and an average true range (ATR) of 0.42.
If we refocus on Roivant Sciences Ltd (NASDAQ:ROIV), historical trading data shows that trading volumes averaged 7.56 million over the past 10 days and 5.30 million over the past 3 months. The company’s latest data on shares outstanding shows there are 760.14 million shares.
The 40.16% of Roivant Sciences Ltd’s shares are in the hands of company insiders while institutional holders own 50.51% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 27.69 million on Feb 29, 2024, giving us a short ratio of 4.61. The data shows that as of Feb 29, 2024 short interest in Roivant Sciences Ltd (ROIV) stood at 3.44% of shares outstanding, with shares short rising to 25.71 million registered in Jan 31, 2024. Current price change has pushed the stock -3.47% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ROIV stock continues to rise going into the next quarter.
